XML 62 R37.htm IDEA: XBRL DOCUMENT
v3.25.0.1

BUSINESS ACQUISITIONS & DISPOSITIONS Business Acquisitions (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024 | Dec. 31, 2023 | Dec. 31, 2022
Business Combinations [Abstract] |  |  |
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed | The purchase price allocations for these acquisitions were preliminary at December 31, 2024. The valuation of acquired assets and assumed liabilities include the following:
| Baystate Medical Center | Providence Medical Foundation | Westpac Labs, Inc. | Invitae Corp. | BioReference Health | Other Business Acquisitions | Measurement Period Adjustments | Amounts Acquired During the Year Ended December 31, 2024
Inventories | $ | — |  | $ | — |  | $ | 1.8 |  | $ | 12.1 |  | $ | — |  | $ | — |  | $ | 2.0 |  | $ | 15.9 |
Prepaid expenses and other | — |  | — |  | — |  | — |  | — |  | — |  | 8.4 |  | 8.4 |
Property, plant and equipment | 7.2 |  | 0.9 |  | — |  | 76.7 |  | 9.1 |  | 1.3 |  | 28.1 |  | 123.3 |
Goodwill | 70.7 |  | 25.9 |  | 45.1 |  | 100.4 |  | 107.4 |  | 41.0 |  | (90.6) |  | 299.9 |
Intangible assets | 79.8 |  | 29.2 |  | 50.8 |  | 113.2 |  | 121.1 |  | 46.2 |  | 44.3 |  | 484.6 |
Total assets acquired | 157.7 |  | 56.0 |  | 97.7 |  | 302.4 |  | 237.6 |  | 88.5 |  | (7.8) |  | 932.1 |
Accrued expenses and other | — |  | — |  | — |  | — |  | — |  | — |  | (3.9) |  | (3.9) |
Unearned revenue | — |  | — |  | — |  | 3.3 |  | — |  | — |  | (3.3) |  | — |
Lease liabilities | 7.2 |  | 0.9 |  | — |  | 58.3 |  | — |  | 0.6 |  | — |  | 67.0 |
Total liabilities acquired | 7.2 |  | 0.9 |  | — |  | 61.6 |  | — |  | 0.6 |  | (7.2) |  | 63.1 |
Net assets acquired | 150.5 |  | 55.1 |  | 97.7 |  | 240.8 |  | 237.6 |  | 87.9 |  | (0.6) |  | 869.0 |
Less 2023 escrow payment | 30.0 |  | — |  | — |  | — |  | — |  | — |  | — |  | 30.0 |
Cash paid for acquisitions | $ | 120.5 |  | $ | 55.1 |  | $ | 97.7 |  | $ | 240.8 |  | $ | 237.6 |  | $ | 87.9 |  | $ | (0.6) |  | $ | 839.0 |
| The purchase price allocations for these acquisitions were preliminary at December 31, 2023. The preliminary valuation of acquired assets and assumed liabilities, include the following:
| Jefferson Health | Enzo BioChem | Providence Health and Services - Oregon | Tufts Medicine | Legacy | Other Business Acquisitions | Measurement Period Adjustments | Amounts Acquired During the Year Ended December 31, 2023
Accounts receivable | $ | — |  | $ | (2.8) |  | $ | — |  | $ | — |  | $ | — |  | $ | 2.0 |  | $ | 0.2 |  | $ | (0.6) |
Inventories | — |  | — |  | 1.3 |  | — |  | — |  | — |  | — |  | 1.3 |
Prepaid expenses and other | — |  | 0.4 |  | — |  | — |  | 0.2 |  | 0.3 |  | 0.6 |  | 1.5 |
Property, plant and equipment | — |  | — |  | 4.7 |  | — |  | 3.3 |  | 6.5 |  | (1.5) |  | 13.0 |
Goodwill | 50.8 |  | 54.1 |  | 50.7 |  | 73.8 |  | 49.0 |  | 18.5 |  | (29.4) |  | 267.5 |
Intangible assets | 57.2 |  | 61.1 |  | 57.2 |  | 83.2 |  | 55.2 |  | 26.9 |  | 19.5 |  | 360.3 |
Other assets | 2.2 |  | — |  | — |  | — |  | — |  | 17.9 |  | — |  | 20.1 |
Total assets acquired | 110.2 |  | 112.8 |  | 113.9 |  | 157.0 |  | 107.7 |  | 72.1 |  | (10.6) |  | 663.1 |
Accounts payable | — |  | — |  | — |  | — |  | — |  | 1.2 |  | — |  | 1.2 |
Accrued expenses and other | — |  | — |  | 3.9 |  | — |  | — |  | 1.2 |  | (8.3) |  | (3.2) |
Deferred income taxes | — |  | — |  | — |  | — |  | — |  | — |  | (2.3) |  | (2.3) |
Other liabilities | — |  | — |  | — |  | — |  | — |  | (4.1) |  | — |  | (4.1) |
Total liabilities acquired | — |  | — |  | 3.9 |  | — |  | — |  | (1.7) |  | (10.6) |  | (8.4) |
Net assets acquired | $ | 110.2 |  | $ | 112.8 |  | $ | 110.0 |  | $ | 157.0 |  | $ | 107.7 |  | $ | 73.8 |  | $ | — |  | $ | 671.5 |
| A summary of the net assets acquired in 2022 for these businesses is included below:
| Preliminary Personal Genome Diagnostics Inc. | Preliminary Ascension Healthcare | Other Acquisitions | Measurement Period Adjustments | Amounts Acquired During Year Ended December 31, 2022
Accounts receivable | $ | 4.1 |  | $ | — |  | $ | (1.3) |  | $ | (2.3) |  | $ | 0.5 |
Unbilled services | 2.9 |  | — |  | — |  | (3.2) |  | (0.3) |
Inventories | 2.5 |  | 24.6 |  | — |  | — |  | 27.1 |
Prepaid expenses and other | 1.2 |  | 0.4 |  | 0.3 |  | — |  | 1.9 |
Property, plant and equipment | 9.9 |  | 43.5 |  | 0.1 |  | — |  | 53.5 |
Deferred income taxes | 17.5 |  | — |  | — |  | 15.2 |  | 32.7 |
Goodwill | 346.8 |  | 125.0 |  | 126.7 |  | (40.4) |  | 558.1 |
Intangible assets | 136.6 |  | 233.2 |  | 172.5 |  | 30.4 |  | 572.7 |
Other assets | 12.5 |  | — |  | 2.3 |  | (2.3) |  | 12.5 |
Total assets acquired | 534.0 |  | 426.7 |  | 300.6 |  | (2.6) |  | 1,258.7 |
Accounts payable | 3.8 |  | — |  | — |  | (0.1) |  | 3.7 |
Accrued expenses and other | 57.3 |  | — |  | 15.4 |  | 0.1 |  | 72.8 |
Unearned revenue | 3.3 |  | — |  | — |  | (2.6) |  | 0.7 |
Lease liabilities | — |  | 2.9 |  | — |  | — |  | 2.9 |
Other liabilities | 14.6 |  | — |  | — |  | — |  | 14.6 |
Total liabilities acquired | 79.0 |  | 2.9 |  | 15.4 |  | (2.6) |  | 94.7 |
Net assets acquired | $ | 455.0 |  | $ | 423.8 |  | $ | 285.2 |  | $ | — |  | $ | 1,164.0 |
Business Acquisition [Line Items] |  |  |
Business Acquisition, Pro Forma Information [Table Text Block] | Had the aggregate of the Company’s 2024 acquisitions been completed at January 1, 2023, the Company’s pro forma results would have been as follows:
| Year Ended December 31,
| 2024 |  | 2023 |
Revenues | $ | 13,353.6 |  |  | $ | 12,716.4 |  |
Net earnings attributable to LHI | $ | 761.8 |  |  | $ | 423.3 |  |
| Had the aggregate of the Company’s 2023 acquisitions been completed at January 1, 2022, the Company’s pro forma results would have been as follows:
| Year Ended December 31,
| 2023 |  | 2022 |
Revenues | $ | 12,350.1 |  |  | $ | 12,126.3 |  |
Earnings from continuing operations | $ | 397.2 |  |  | $ | 1,030.3 |  |
| Had the aggregate of the Company’s 2022 acquisitions been completed at January 1, 2021, the Company’s pro forma results would have been as follows:
| Year Ended December 31,
| 2022 |  | 2021 |
Revenues | $ | 11,984.7 |  |  | $ | 13,325.7 |  |
Earnings from continuing operations | $ | 1,006.8 |  |  | $ | 2,182.4 |  |

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5 + Details
Name: | us-gaap_BusinessAcquisitionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -SubTopic 10 -Topic 805 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(3) -SubTopic 10 -Topic 805 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2 + Details
Name: | us-gaap_BusinessAcquisitionProFormaInformationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_BusinessCombinationsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Paragraph 1 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1 + Details
Name: | us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration